Literature DB >> 4086563

Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.

P L Stetson, U A Shukla, W D Ensminger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4086563     DOI： 10.1016/s0378-4347(00)82045-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer.

Authors:  A Hageboutros; G R Hudes; F Greene; F P LaCreta; J Brennan; P J O'Dwyer
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

2.  A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions.

Authors:  H Bailey; G Wilding; K D Tutsch; R Z Arzoomanian; D Alberti; M B Tombes; J L Grem; D R Spriggs
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.

Authors:  A Hageboutros; A Rogatko; E M Newman; C McAleer; J Brennan; F P LaCreta; G R Hudes; R F Ozols; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside.

Authors:  A Hageboutros; G R Hudes; J Brennan; F Green; J Hoffman; F P LaCreta; J Colofiore; D S Martin; R F Ozols; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

5.  Bioavailability and feasibility of subcutaneous 5-fluorouracil.

Authors:  M M Borner; J Kneer; C Crevoisier; K W Brunner; T Cerny
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

6.  Methods for direct determination of mitomycin C in aqueous solutions and in urine.

Authors:  Dolores Marín; Pedro Pérez; Carmen Teijeiro; Emil Palecek
Journal:  Biol Proced Online       Date:  1998-09-17       Impact factor: 3.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.